Who’s Going to World Vaccine Congress 2027
Mar 8–11, 2027 Washington, DC ~3k attendees Website
222 organizations and 185 speakers at World Vaccine Congress 2027, a ~3,000-person, mostly industry meeting of vaccine R&D, manufacturing and regulatory leaders. As of Oct 8, 2026.
| Organization | World Vaccine Congress 2027 Attendance |
|---|---|
CEPI Oslo, Norway | |
Coalition for Epidemic Preparedness Innovations: global partnership funding vaccines against emerging infectious diseases and epidemic threats. | Talk Wed Mar 10 09:10 Panel Wed Mar 10 09:10 Talk Wed Mar 10 16:40 Deep Dive Session: Non-animal preclinical systems for vaccine development and pandemic preparedness How organoids and organ-on-chip systems could replace some animal studies in early vaccine testing and pandemic preparedness. |
Sanofi Paris, France | |
Global pharmaceutical company with a large vaccines business spanning influenza, pediatric, meningitis and mRNA programs. | Booth Exhibiting (no floor booth listed) Chair Wed Mar 10 09:00 Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. Talk Wed Mar 10 15:40 |
Pfizer New York, NY | |
Global pharmaceutical company with a vaccine portfolio spanning pneumococcal, RSV, COVID-19 and other infectious diseases. | Keynote Tue Mar 9 14:55 The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide. Clinical & preclinical developmentSupply, safety & access Talk Wed Mar 10 15:10 |
Boston Children's Hospital Boston, MA | |
Pediatric teaching hospital of Harvard Medical School, home to the Precision Vaccines Program. | Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. Talk Wed Mar 10 09:10 |
University of Pennsylvania Philadelphia, PA | |
Research university whose Perelman School of Medicine pioneered the modified mRNA used in COVID-19 vaccines. | Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. Talk Wed Mar 10 12:30 Talk Thu Mar 11 09:40 |
Eli Lilly Indianapolis, IN | |
Global pharmaceutical company whose medicines span diabetes, obesity, oncology, immunology and neuroscience, with antibody research against infectious diseases. | Talk Mon Mar 8 10:00 Antibodies for Infectious Diseases Workshop Research on antibody medicines that treat or prevent infectious diseases. Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. |
Integrated network of US clinical research sites with a long track record in vaccine trials. | Booth Exhibiting at Booth 204 |
Epstein Becker Green New York, NY | |
US law firm focused on health care and life science law, including regulatory and employment matters. | Keynote Thu Mar 11 13:40 |
International Vaccine Institute Seoul, South Korea | |
International non-profit organization developing and delivering vaccines for global health. | Keynote Tue Mar 9 09:30 Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg. Infectious disease & AMR |
Moderna Cambridge, MA | |
mRNA medicines company with marketed vaccines against COVID-19 and RSV, and mRNA candidates for influenza, other infections and cancer. | Chair Wed Mar 10 09:00 |
Callen-Lorde New York, NY | |
Community health center providing primary care and sexual health services to LGBTQ communities in New York City. | Talk Mon Mar 8 10:00 HIV Vaccines Workshop Where the search for an HIV vaccine stands, from laboratory advances and ongoing clinical trials to plans for fair global access. Keynote Thu Mar 11 14:20 Closing Keynote: Reimagining public health infrastructure in the USA – opportunities to rebuild with intention How the US could rebuild its public health system for the long term, from disease forecasting and biodefense to universal vaccine access. Supply, safety & access |
National University of San Martín San Martín, Argentina | |
Argentine public university whose researchers developed ARVAC, a recombinant protein COVID-19 vaccine. | Talk Wed Mar 10 12:25 |
360biolabs Melbourne, Australia | |
Australian specialist laboratory running virology, immunology and serology assays for vaccine and infectious disease trials. | Booth Exhibiting at Booth 357 Panel Wed Mar 10 14:40 |
Swedish company supplying immunoassays and instruments for ELISpot, FluoroSpot, ELISA and multiplex analysis. | Booth Exhibiting at Booth 377 |
Instantly find 20 buyers from companies at World Vaccine Congress 2027
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
When and where is World Vaccine Congress 2027?
World Vaccine Congress Washington 2027 runs March 8–11, 2027, at the Walter E. Washington Convention Center in Washington, DC.
Where is the World Vaccine Congress 2027 program?
This guide lists every organization on the World Vaccine Congress 2027 program with its sessions; the full program is on the official website.
How do I register for World Vaccine Congress 2027?
Fees and registration are on the organizer's registration page.
What conference is this?
The World Vaccine Congress Washington is the World Vaccine Congress series’ flagship annual meeting, held March 8–11, 2027 at the Walter E. Washington Convention Center in Washington, DC, with pre-congress workshops on March 8. It brings together vaccine R&D, clinical, manufacturing, regulatory and public-health leaders from industry, government, academia and global health with the CROs, CDMOs and suppliers that serve them, across tracks on influenza and respiratory diseases, emerging diseases, pandemic platforms, cancer and immunotherapy, clinical trials, immune profiling, bioprocessing and manufacturing, vaccine access, safety, supply and logistics, partnerships, and veterinary and One Health.
What is in this guide?
Every organization we can place at World Vaccine Congress 2027: 185 speakers from the public program and speaker list (60 sessions so far) rolled up to their companies and institutions, plus the 107 sponsors and exhibitors from the public listing and floor plan with their stand numbers where published — 222 organizations in one list. Speakers appear as job titles, never by name.
How are organizations typed?
By the role an organization plays in vaccine development: vaccine and drug developers (large pharma and biotech), then the companies around them — CROs, CDMOs and testing labs, bioprocess and manufacturing suppliers, reagents, assays and analytics, software, consulting and other services — and academic and public-health bodies. The topic filters come from the track a session sits in, and for keynotes from the session’s own title and description.
How current is it?
Pulled from the public agenda, speaker list, sponsor and exhibitor listing and floor plan on October 8, 2026, five months before the meeting. The agenda is still filling in, so more sessions and speakers will follow. Stand numbers come from the organizer’s floor plan; the exhibition’s opening hours are not published yet.
Browse World Vaccine Congress 2027 by
Organizations with their own page
120 organizations — every exhibitor and every organization with 2 or more presentations.
- 360biolabs
- ABL
- Acuitas Therapeutics
- Advanced Technology International
- Advanced Virology
- Africa CDC
- Agilent
- Alliance Clinical Network
- Ambient Biosciences
- AMR Clinical
- Aptar Pharma
- ARCALIS
- Areti Health
- Battelle
- BIKEN
- Biobot Analytics
- Biodextris
- Boston Children's Hospital
- Brand Institute
- Callen-Lorde
- Carterra
- CEPI
- Cerba Research
- Chongqing BDSyn Biotech
- Claryx
- Clean Biologics
- Cores
- CRIO
- Croda
- CTI Clinical Trial and Consulting Services
- CTL (Cellular Technology Limited)
- Cytiva
- Cytovance Biologics
- Daicel Life Sciences
- Desert King
- DM Clinical Research
- Dr. Vince Clinical Research
- Eli Lilly
- Elite Clinical Network
- Elite Research Network
- Emmes
- EmVenio
- Endpoints
- Evax
- Fabentech
- Fina BioSolutions
- Headlands Research
- HIPRA
- HJF (Henry M. Jackson Foundation)
- hVIVO
- Iaso Therapeutics
- IBT Bioservices
- ICON
- IDT Biologika
- ImmunAdd
- Inaedis
- Integral Molecular
- Interspond
- Intravacc
- iProcess Global Research
- IQVIA Laboratories
- Javara
- JCCT
- Kindeva Drug Delivery
- LTS Lohmann
- Mabtech
- Mayo Clinic
- Microbiologics
- MLM Medical Labs
- ModeX Therapeutics
- MTH
- National University of San Martín
- Novo Nordisk Pharmatech
- OMNI CRS
- Omniose
- Optimal Clinical Trials
- P95
- Pacto Medical
- Parexel
- PassPort Technologies
- Pegasus Biotech
- Pfizer
- PharmaJet
- Populace Health
- PPD (Thermo Fisher Scientific)
- Pratia
- Premas Biotech
- Primrose Bio
- Quantoom Biosciences
- Recipharm
- Revival Research Institute
- RheoSense
- Sabin Vaccine Institute
- Samyang Biopharm
- Sanofi
- SeromYx Systems
- Southern Research
- SPI Pharma
- SpotSee
- SSI Diagnostica
- Syneos Health
- Techsol Life Sciences
- Total Trials
- TPRA – The Patient Recruiting Agency
- Tribe Clinical Research
- UK Health Security Agency (UKHSA)
- Unither Pharmaceuticals
- University of Pennsylvania
- University of Texas Medical Branch
- Vaxart
- Vaxcyte
- VaxSyna
- VIDO (Vaccine and Infectious Disease Organization)
- VisMederi
- VMRD
- Wacker Biotech
- Weill Cornell Medicine
- WISE-R
- World BioHazTec
- WuXi Vaccines
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction